BioCentury | Sep 22, 2014
Company News

OvaScience management update

OvaScience Inc. (NASDAQ:OVAS), Cambridge, Mass. Business: Genitourinary Hired: Jeffrey Young as CFO, formerly CFO and treasurer of Transmedics Inc. WIR Staff Genitourinary...
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Jul 2, 2012
Finance

3Q Financial Markets Preview: Miles of milestones

...PDUFA date August Pharming Group N.V. (Euronext:PHARM)/Hyupjin Corp. /MegaPharm Ltd./Santarus Inc. (NASDAQ:SNTS)/Swedish Orphan Biovitrum AB (SSE:SOBI)/Transmedic Pte. Ltd....
BioCentury | Apr 2, 2012
Company News

Hyupjin, Pharming sales and marketing update

...San Diego, Calif.) has exclusive commercialization rights to conestat alfa as Rhucin in North America. Transmedic Pte. Ltd....
BioCentury | Feb 20, 2012
Company News

Pharming, Transmedic sales and marketing update

...Pharming granted Transmedic commercialization rights to Ruconest conestat alfa in Brunei, Indonesia, Malaysia, the Philippines, Singapore...
...Indonesia, Malaysia, the Philippines, Singapore and Thailand to treat acute attacks of hereditary angioedema (HAE). Transmedic...
...to conestat alfa as Rhucin in North America. Pharming Group N.V. (Euronext:PHARM), Leiden, the Netherlands Transmedic Pte. Ltd....
Items per page:
1 - 5 of 5
BioCentury | Sep 22, 2014
Company News

OvaScience management update

OvaScience Inc. (NASDAQ:OVAS), Cambridge, Mass. Business: Genitourinary Hired: Jeffrey Young as CFO, formerly CFO and treasurer of Transmedics Inc. WIR Staff Genitourinary...
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Jul 2, 2012
Finance

3Q Financial Markets Preview: Miles of milestones

...PDUFA date August Pharming Group N.V. (Euronext:PHARM)/Hyupjin Corp. /MegaPharm Ltd./Santarus Inc. (NASDAQ:SNTS)/Swedish Orphan Biovitrum AB (SSE:SOBI)/Transmedic Pte. Ltd....
BioCentury | Apr 2, 2012
Company News

Hyupjin, Pharming sales and marketing update

...San Diego, Calif.) has exclusive commercialization rights to conestat alfa as Rhucin in North America. Transmedic Pte. Ltd....
BioCentury | Feb 20, 2012
Company News

Pharming, Transmedic sales and marketing update

...Pharming granted Transmedic commercialization rights to Ruconest conestat alfa in Brunei, Indonesia, Malaysia, the Philippines, Singapore...
...Indonesia, Malaysia, the Philippines, Singapore and Thailand to treat acute attacks of hereditary angioedema (HAE). Transmedic...
...to conestat alfa as Rhucin in North America. Pharming Group N.V. (Euronext:PHARM), Leiden, the Netherlands Transmedic Pte. Ltd....
Items per page:
1 - 5 of 5